In English | En español

National Cancer Institute

at the National Institutes of Health

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Clinical Trials Search Results

Page Options

Email This Document

Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat

Popular Resources

Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-25 of 37 for your search:

Drug:  furosemide
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Phase II/III Chemotherapy with MVP (MITO/VBL/CACP) vs CHIP vs CBDCA vs VBL/CACP vs MVP-CAMP (MITO/VBL/CACP/CTX/ADR/MTX/PCB) in Patients with Metastatic (Stage III) non-Small Cell Bronchogenic Carcinoma

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1583

Phase III Study with CACP vs ADR/CTX/CACP & Phase II Study with VM-26 for Disseminated Transitional Cell Urinary Tract Cancer

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: EST-1878

Phase III Randomized Comparison of MTX vs Cyclosporin-A for Prevention of Graft-Versus-Host Disease in Patients with ANLL in First Remission Receiving BMT from HLA-Identical Family Members

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 50
Sponsor:
Protocol IDs: FHCRC-122, NCI-V83-0098

Phase III Chemoradiotherapy with CTX and TBI plus Allogeneic Marrow Transplantation and Post-Transplant MTX Immunosuppression for Hematologic Malignancies in Remission or Relapse

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: FHCRC-84, NCI-V83-0094

Phase II Chemotherapy with L-PAM in Patients with Metastatic Colorectal Carcinoma

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8373

Phase I/II Pilot Combination Chemotherapy with Intraperitoneal L-PAM/CACP in Patients with Stage III/IV Ovarian Cancer

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PD-882, EST-P-D882

Phase I/II Intrapleural Combination Chemotherapy with CACP/ARA-C in Patients with Malignant Involvement of the Pleura

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCSD-84124, NCI-V85-0023

Phase I/II Master Protocol Pilot Evaluation of Single-Agent or Combination Chemotherapy for Stage III Myeloma --- High-Dose L-PAM/CTX (Summary Last Modified 01/88)

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8512, CALGB-8512

Phase I/II High-Dose Combination Chemotherapy with CTX/ARA-C/AMSA/CACP plus TBI and Autologous Bone Marrow Therapy for Refractory Diffuse Aggressive Lymphomas and Hodgkin's Disease

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-83-C-215, NCI-MB-187, NCI-T84-0257N

10.

Phase I Evaluation of Intraperitoneal ARA-C and CACP in Patients with Tumors Confined to the Abdomen and Phase II Chemotherapy with Intraperitoneal ARA-C and CACP in Patients with Ovarian Carcinoma

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-PPC-869, NCI-V85-0192

11.

Phase II Chemotherapy with VBL/CACP/BLEO for Metastatic Nonseminomatous Testicular Cancer

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-048-130, WCCC-CO-7881

12.

Phase II Chemotherapy with CACP/ADR in Patients with Advanced Prostatic Adenocarcinoma

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: NCI-D78-048-141, WCCC-CO-7883

13.

Phase II Sequential Chemotherapy with CTX Followed by High-Dose L-Pam for Refractory Acute Leukemia, Lymphoma, and Selected Solid Tumors

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: NCI-D79-017-183

14.

Phase II Chemotherapy with CACP for Refractory Sarcomas and Gastrointestinal Neoplasms

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-21377

15.

Phase II Pilot Combination Chemotherapy with FUVAC (5-FU/VBL/ADR/CTX) Followed by High-Dose CTX plus Autologous Marrow for Good-Risk Patients or Hemibody Irradiation in Poor-Risk Patients with Metastatic or Recurrent Breast Cancer

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8278

16.

Phase II Pilot Study of CACP/BLEO/Standard-Dose MTX with Leucovorin Rescue for Advanced or Refractory Squamous Cell Carcinoma of the Uterine Cervix

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PA-881

17.

Phase II Chemotherapy with L-PAM for Refractory Carcinoma of the Breast, Small Cell Lung Carcinoma, and Soft Tissue Sarcoma

Phase: Phase II
Type: Treatment
Status: Completed
Age: under 65
Sponsor:
Protocol IDs: NCI-D80-018-135, DFCI-79047

18.

Phase II Chemotherapy with MITO/VP-16/CACP/HMM for Advanced Lung Cancer Refractory to Standard Therapy

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: NCI-D80-055-200

19.

Phase II High-Dose L-PAM and Autologous Bone Marrow Reinfusion for Advanced Small Cell Lung Cancer and Head and Neck Cancer (Stage III/IV)

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-045-549

20.

Phase II Marrow Ablation and Autologous Bone Marrow Therapy with and without Monoclonal Antibody Treatment of Marrow in Patients with ANLL in First Remission

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: FHCRC-132, NCI-V83-0102

21.

Phase II Chemotherapy with CTX plus TBI Followed by Autologous Marrow Infusion for Poor Prognosis Patients with Malignant Lymphoma, Breast Cancer, Ovarian Carcinoma, and Pediatric Solid Tumors

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 66
Sponsor:
Protocol IDs: FHCRC-82, NCI-V83-0093

22.

Phase II Marrow Ablation with CTX plus TBI Followed by Allogeneic Marrow Transplantation, Immunosuppression, and CNS Prophylaxis in Patients with High-Risk Malignant Lymphoma (Summary Last Modified 06/88)

Phase: Phase II
Type: Treatment
Status: Closed
Age: 9 to 50
Sponsor: NCI
Protocol IDs: FHCRC-164.2, NCI-H83-0109

23.

Phase II Marrow Ablation with CTX plus TBI Followed by Autologous Bone Marrow Infusion in Patients with Malignant Lymphoma, with Pilot Study of Monoclonal Antibody Treatment of Marrow (Summary Last Modified 02/91)

Phase: Phase II
Type: Treatment
Status: Closed
Age: 60 and under
Sponsor:
Protocol IDs: FHCRC-159.1, NCI-V83-0110

24.

Phase II Chemoradiotherapy plus Syngeneic Bone Marrow Transplantation with Randomized Trial of Syngeneic Peripheral Blood Lymphocytes in Patients with Hematologic Malignancy (Summary Last Modified 01/90)

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 66
Sponsor:
Protocol IDs: FHCRC-27.3, NCI-V83-0091

25.

Phase II Chemotherapy with CACP in Patients with Gastric Carcinoma Resistant to Standard Chemotherapy

Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: EORTC-40793

Select All on Page

Help with Results

We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat

NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map